Puneet Souda
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
213
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $34.31 | +16.58% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $124.16 | +20.81% | 7 | Oct 17, 2024 | |
| HOLX Hologic | Maintains: Outperform | $95 → $90 | $82.33 | +9.32% | 6 | Oct 8, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $387.21 | -3.15% | 15 | Aug 1, 2024 | |
| MYGN Myriad Genetics | Upgrades: Outperform | $25 → $35 | $17.99 | +94.55% | 6 | May 8, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $7.15 | +39.86% | 6 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $557.92 | +12.92% | 19 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $33.15 | +5.58% | 11 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $136.87 | +5.94% | 19 | May 24, 2023 | |
| DHR Danaher | Initiates: Outperform | $300 | $247.76 | +21.08% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $149.76 | +66.93% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $75.31 | +46.06% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $69.80 | +7.45% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $138.61 | +44.29% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $20 | $3.46 | +478.03% | 5 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $2.73 | +559.34% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $4.18 | +43.54% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $41.57 | -27.83% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $12 → $15 | $13.43 | +11.69% | 11 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $15 | $14.00 | +7.14% | 9 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $59.29 | +46.74% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $23.00 | +508.70% | 5 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20,000 → $15,000 | $0.85 | +1,762,739.35% | 5 | Jan 27, 2021 |
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $34.31
Upside: +16.58%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $124.16
Upside: +20.81%
Hologic
Oct 8, 2024
Maintains: Outperform
Price Target: $95 → $90
Current: $82.33
Upside: +9.32%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $387.21
Upside: -3.15%
Myriad Genetics
May 8, 2024
Upgrades: Outperform
Price Target: $25 → $35
Current: $17.99
Upside: +94.55%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $7.15
Upside: +39.86%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $557.92
Upside: +12.92%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $33.15
Upside: +5.58%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $136.87
Upside: +5.94%
Danaher
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $247.76
Upside: +21.08%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $149.76
Upside: +66.93%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $75.31
Upside: +46.06%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $69.80
Upside: +7.45%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $138.61
Upside: +44.29%
Jan 6, 2023
Maintains: Outperform
Price Target: $25 → $20
Current: $3.46
Upside: +478.03%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.73
Upside: +559.34%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $4.18
Upside: +43.54%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $41.57
Upside: -27.83%
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $13.43
Upside: +11.69%
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $14.00
Upside: +7.14%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $59.29
Upside: +46.74%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $23.00
Upside: +508.70%
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $0.85
Upside: +1,762,739.35%